BioPhase 8800 system with native fluorescence – Same foundation, more muscle

Capillary electrophoresis (CE) has long supported biopharma innovation, but evolving therapeutic demands require greater sensitivity and speed. Discover how native fluorescence and streamlined CE workflows enable faster, more confident impurity analysis. These approaches help to reduce noise, simplify preparation, and accelerate charge heterogeneity profiling for advanced biologics, mRNA drugs, and protein therapeutics.